Drawing for TIURA

USPTO serial 78049888

TIURA

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
PERKINS, ELLEN J
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with TIURA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases and auto-immune diseasesABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 17, 2002ABN5ABANDONMENT - AFTER PUBLICATION—
Oct 25, 2002MAILPAPER RECEIVED—
May 15, 2002ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Apr 2, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 13, 2002NPUBNOTICE OF PUBLICATION—
Jan 18, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 15, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 30, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 11, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance